Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020142625 - COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE

Publication Number WO/2020/142625
Publication Date 09.07.2020
International Application No. PCT/US2020/012081
International Filing Date 02.01.2020
Chapter 2 Demand Filed 30.11.2020
IPC
C07K 16/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
A61P 37/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61P 37/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
C07K 16/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
C07K 16/18
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
C07K 16/283
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
2803against the immunoglobulin superfamily
283against Fc-receptors, e.g. CD16, CD32, CD64
C07K 2317/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
20characterized by taxonomic origin
Applicants
  • INVETX INC. [US]/[US]
Inventors
  • BRONDYK, William
  • CHEVALIER, Brett
  • HORN, Juergen
  • NATARAJAN, Madhusudan
Agents
  • XING, Liujing
  • KOIPALLY, Joseph J.
Priority Data
62/788,03503.01.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMPOSITIONS FOR INCREASING HALF-LIFE OF A THERAPEUTIC AGENT IN CANINES AND METHODS OF USE
(FR) COMPOSITIONS POUR AUGMENTER LA DEMI-VIE D'UN AGENT THÉRAPEUTIQUE CHEZ LES CHIENS ET PROCÉDÉS D'UTILISATION
Abstract
(EN)
Provided are compositions for increasing the half-life of a polypeptide or polypeptides in a canine and methods of their use. The compositions involve variant canine IgG Fc regions.
(FR)
L'invention concerne des compositions pour augmenter la demi-vie d'un polypeptide ou de polypeptides chez les chiens et des procédés d'utilisation de celles-ci. Les compositions impliquent des régions Fc d'IgG canines variantes.
Latest bibliographic data on file with the International Bureau